Patient Preferences in Metastatic Breast Cancer Care: A Scoping Review

被引:5
作者
Bland, Kelcey A. [1 ,2 ]
Mustafa, Reem [1 ,3 ]
McTaggart-Cowan, Helen [1 ,3 ]
机构
[1] BC Canc Res Inst, Canc Control Res, Vancouver, BC V5Z 1L3, Canada
[2] Univ British Columbia, Dept Phys Therapy, Vancouver, BC V6T 1Z4, Canada
[3] Simon Fraser Univ, Fac Hlth Sci, Burnaby, BC V5A 1S6, Canada
关键词
breast cancer; conjoint analysis; discrete choice experiment; healthcare provider preferences; metastases; oncology; patient preferences; preference elicitation; qualitative research; review; QUALITY-OF-LIFE; PREOPERATIVE RADIOTHERAPY; CONJOINT-ANALYSIS; DECISION-MAKING; PALLIATIVE CARE; WOMEN; DISEASE; BURDEN; ATTRIBUTES; SYMPTOMS;
D O I
10.3390/cancers15174331
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Simple Summary Identifying and understanding patient preferences regarding their own care can help to tailor cancer therapies and services to the needs, goals, and values of patients. Currently, research on the preferences of patients with metastatic breast cancer (MBC) regarding their care has not been summarized. Our review aims to summarize all research reporting on the specific preferences of patients with MBC regarding their care to identify important areas for future research. The main finding of the current review is that to-date studies evaluating preferences among patients with MBC are mixed. Most studies on MBC patient preferences have focused on capturing preferences directly relating to cancer treatments. More information on patient preferences for other aspects of MBC care, including supportive care therapies and services that target physical, mental, and emotional quality of life, is needed.Abstract People with metastatic breast cancer (MBC) have diverse medical, physical, and psychosocial needs that require multidimensional care. Understanding patient preferences is crucial to tailor treatments, services, and foster patient-centered care. A scoping review was performed to summarize the current evidence on the preferences of people with MBC regarding their care to identify knowledge gaps and key areas for future research. The Embase, MEDLINE, CINAHL and PsycInfo databases were searched. Twenty studies enrolling 3354 patients met the study eligibility criteria. Thirteen quantitative studies, four mixed methods studies, and three qualitative studies were included. Seven studies captured healthcare provider perspectives; thirteen studies evaluated patient preferences relating specifically to cancer treatments; three studies evaluated preferences relating to supportive care; and four studies evaluated communication and decision-making preferences. The current literature evaluating MBC patient preferences is heterogeneous with a focus on cancer treatments. Future research should explore patient preferences relating to multidisciplinary, multi-modal care that aims to improve quality of life. Understanding MBC patient preferences regarding their comprehensive care can help tailor healthcare delivery, enhance the patient experience, and improve outcomes.
引用
收藏
页数:16
相关论文
共 63 条
  • [1] Benefit-risk trade-offs in treatment choice in advanced HER2 negative breast cancer: patient and oncologist perspectives
    Amin, Suvina
    Tolaney, Sara M.
    Cambron-Mellott, M. Janelle
    Beusterien, Kathleen
    Maculaitis, Martine C.
    Mulvihill, Emily
    Shinde, Reshma
    McLaurin, Kimmie
    [J]. FUTURE ONCOLOGY, 2022, 18 (16) : 1927 - 1941
  • [2] Patient-Clinician Communication Issues in Palliative Care for Patients With Advanced Cancer
    Back, Anthony L.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (09) : 866 - +
  • [3] Longitudinal Symptom Burden Trajectories in a Population-Based Cohort of Women with Metastatic Breast Cancer: A Group-Based Trajectory Modeling Analysis
    Budhwani, Suman
    Moineddin, Rahim
    Wodchis, Walter P.
    Zimmermann, Camilla
    Howell, Doris
    [J]. CURRENT ONCOLOGY, 2021, 28 (01) : 879 - 897
  • [4] Communicating prognosis to patients with metastatic disease: what do they really want to know?
    Butow, PN
    Dowsett, S
    Hagerty, R
    Tattersall, MHN
    [J]. SUPPORTIVE CARE IN CANCER, 2002, 10 (02) : 161 - 168
  • [5] Evolving psychosocial, emotional, functional, and support needs of women with advanced breast cancer: Results from the Count Us, Know Us, Join Us and Here & Now surveys
    Cardoso, Fatima
    Harbeck, Nadia
    Mertz, Shirley
    Fenech, Doris
    [J]. BREAST, 2016, 28 : 5 - 12
  • [6] Palliative care: needs of advanced breast cancer patients
    Cherny, Nathan I.
    Paluch-Shimon, Shani
    Berner-Wygoda, Yael
    [J]. BREAST CANCER-TARGETS AND THERAPY, 2018, 10 : 231 - 243
  • [7] Phase III study to evaluate patient's preference of subcutaneous versus intravenous trastuzumab in HER2-positive metastatic breast cancer patients: Results from the ChangHER study (GEICAM/2012-07)
    Ciruelos, Eva M.
    Montano, Alvaro
    Rodriguez, Cesar A.
    Gonzalez-Flores, Encarnacion
    Lluch, Ana
    Garrigos, Laia
    Quiroga, Vanesa
    Anton, Antonio
    Malon, Diego
    Chacon, Jose, I
    Velasco, Montserrat
    Gonzalez-Cortijo, Lucia
    Jolis, Laura
    Echarri, Maria J.
    Munoz, Montse
    Pascual, Tomas
    Amigo, Yolanda
    Casas, Maribel
    Carrasco, Eva
    Casas, Ana
    [J]. EUROPEAN JOURNAL OF CANCER CARE, 2020, 29 (04)
  • [8] Burden of symptoms associated with development of metastatic bone disease in patients with breast cancer
    Cleeland, Charles
    von Moos, Roger
    Walker, Mark S.
    Wang, Yuanyuan
    Gao, Jianqing
    Chavez-MacGregor, Mariana
    Liede, Alexander
    Arellano, Jorge
    Balakumaran, Arun
    Qian, Yi
    [J]. SUPPORTIVE CARE IN CANCER, 2016, 24 (08) : 3557 - 3565
  • [9] Final results from IMPROVE: a randomized, controlled, open-label, two-arm, cross-over phase IV study to determine patients' preference for everolimus in combination with exemestane or capecitabine in combination with bevacizumab in advanced HR-positive, HER2-negative breast cancer
    Decker, Thomas
    Soeling, Ulrike
    Hahn, Antje
    Maintz, Christoph
    Kurbacher, Christian Martin
    Vehling-Kaiser, Ursula
    Sent, Dagmar
    Klare, Peter
    Hagen, Volker
    Chiabudini, Marco
    Falkenstein, Julia
    Indorf, Martin
    Runkel, Eva
    Potthoff, Karin
    [J]. BMC CANCER, 2020, 20 (01)
  • [10] Physical activity preferences before and after participation in a 6-month physical activity intervention among women with metastatic breast cancer
    Delrieu, Lidia
    Vallance, Jeff K.
    Morelle, Magali
    Fervers, Beatrice
    Pialoux, Vincent
    Friedenreich, Christine
    Dufresne, Armelle
    Bachelot, Thomas
    Heudel, Pierre-Etienne
    Tredan, Olivier
    Perol, Olivia
    Touillaud, Marina
    [J]. EUROPEAN JOURNAL OF CANCER CARE, 2020, 29 (01)